Vulcan’s lithium extraction test work to pave the way for PFS

|

Published 07-APR-2020 14:27 P.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Shares in Vulcan Energy Resources Ltd (ASX:VUL) surged 14% after management confirmed the commencement of lithium processing test work at its Vulcan Zero Carbon LithiumTM Project in Germany, the largest lithium resource in Europe, which it is rapidly developing.

Following positive results from the recently completed Scoping Study on the Vulcan Project, the company is progressing with its test work programme to advance its innovative Zero Carbon LithiumTM flowsheet.

The Scoping Study showed the potential for production of battery-quality lithium hydroxide monohydrate products from the project, which could be produced with a uniquely net zero carbon footprint.

Management believes this will be a premium, highly desirable product for the European electric vehicle market.

The Test Work Programme includes the use of geothermal brine for Direct Lithium Extraction (DLE) test work, a process that will initially be conducted off-site.

DLE extraction methods are well developed having been previously piloted on geothermal brines and these will be demonstrated with a focus on process routes which will enable Zero Carbon LithiumTM production and minimal operating costs.

DLE will be demonstrated at bench scale in preparation for pilot scale test work on-site in Germany, planned for this year, with the results of both being incorporated into Vulcan’s Pre-Feasibility Study (PFS).

Commenting on these developments in the context of volatile markets, managing director Francis Wedin said, “Despite globally turbulent times, we are maintaining our momentum by pushing ahead with developing and technically de-risking our globally important Zero Carbon LithiumTM project.

‘’This next step of lithium extraction test work will provide us with valuable data which will be used in our PFS.”

Pathway to becoming first producer of zero carbon lithium

In developing its technology, management aims to decarbonise the currently high carbon production footprint of lithium-ion batteries used in electric vehicles.

On this note Wedin said, ‘’We plan to produce a world-first Zero Carbon LithiumTM hydroxide product from our Vulcan geothermal lithium brine project.

‘’It is the largest lithium resource in Europe and located in the heart of the European Union.

‘’We will use our proprietary Zero Carbon LithiumTM process, married with our unique and very large lithium resource, to pump up hot lithium-rich brine to the surface, then use the renewable heat to drive lithium extraction, with renewable energy as a saleable by-product.’’



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X